Campaign funding from Health Insurance and Pharma blocks hopes for Single-Payer enthusiasts

by Josh Finkelstein. January 31, 2018. OpenSecrets.org.

Excerpts only. Read complete article here. 

Senator Bernie Sanders of Vermont hosted a town hall recently to discuss the Medicare for All Act, during which he emphasized a conflict of interest around involving the private sector in healthcare.

“Right now, we have a healthcare system that is not designed to provide quality care to all people in a cost effective way,” Sanders said at the town hall. “Let us be frank, we have a healthcare system designed to make enormous profits for insurance companies and drug companies. And disease prevention is not very high on their lists.”

Sanders isn’t alone in his sentiment. A number of polls last year (see here, here, and here) indicate that a growing plurality of Americans support switching to a single-payer healthcare system, including a substantial majority of Democrats.

. . .

However, Congress may be slow to respond to the growing interest in the healthcare model found in Canada and across much of Western Europe. The influence-wielding of insurance and pharmaceutical companies appears to be a barrier preventing Congress from embracing single-payer.

A Center for Responsive Politics analysis found a correlation between congressional Democrats’ support for single-payer proposals and contributions received from the health insurance and pharmaceutical industries. One-third of Senate Democrats have cosponsored the Medicare for All Act, which Sanders introduced in September.

Democrats who haven’t cosponsored the bill received 146 percent more money on average from health insurance companies between 2011 and 2016 than those who have ($147,186 to $59,789) and 60 percent more from pharma ($252,369 to $157,768).

. . .

Unsurprisingly, party leaders received the most contributions from the health industry in both houses.

Senate Minority Leader Chuck Schumer (D-Ny.) led his caucus in donations from health insurance companies and ranks third in donations from pharmaceutical companies between 2011 and 2016. Schumer has not committed to supporting the bill.

House Minority Whip Steny Hoyer (D-Md.) received the most donations from health insurance companies and second most from pharma in his caucus between 2015 and 2016 and does not support single-payer.

. . .

Congressional Democrats’ ties to the health insurance and pharmaceutical industries have long been tight. Former Democratic House Speaker Dick Gephardt of Missouri owns the lobbying firm Gephardt Group, which has lobbied on behalf of such clients as UnitedHealth Group and Bayer, its highest-paying client last year.

Gephardt was asked by The Intercept for his thoughts on the prospect of a single-payer system.

“Not in my lifetime,” he replied.

Follow these links to see the influence and lobbying profiles of the health insurance and pharmaceutical industries.

Read complete article here.